39 results
424B1
AXDX
Accelerate Diagnostics Inc
22 Jan 24
Prospectus with pricing info
9:59pm
device reporting regulations, we are required to report to the FDA any incident in which information reasonably suggests that our product may have
S-1/A
AXDX
Accelerate Diagnostics Inc
16 Jan 24
IPO registration (amended)
7:18am
. Under the FDA’s medical device reporting regulations, we are required to report to the FDA any incident in which information reasonably suggests
S-1/A
EX-1.1
AXDX
Accelerate Diagnostics Inc
16 Jan 24
IPO registration (amended)
7:18am
with the Blue Sky survey; (iv) all fees and expenses in connection with listing the Shares and Warrant Shares on Nasdaq; (v) the filing fees incident … , and the cost of aircraft and other transportation chartered in connection with the road show; and (ix) all other costs and expenses incident
S-1
0rj6fm5xng2jt2e418
13 Dec 23
IPO registration
5:30pm
8-K
EX-10.8
wpc00ecbmfo2io449j
13 Jun 23
Entry into a Material Definitive Agreement
9:06am
8-K
EX-10.7
u327j
13 Jun 23
Entry into a Material Definitive Agreement
9:06am
8-K
EX-1.1
jc5udo
23 Aug 22
Accelerate Diagnostics Announces Proposed Public Offering of Common Stock
4:11pm
8-K
EX-10.1
glu 2rhsh0m
25 Mar 22
Entry into a Material Definitive Agreement
3:00pm
8-K
EX-10.2
oeuvh lss7
23 Sep 21
Entry into a Material Definitive Agreement
9:16am
8-K
EX-10.1
s36uzm90f5b38i 2js
23 Sep 21
Entry into a Material Definitive Agreement
9:16am
8-K
EX-1.1
z5bw2bgakbm9
28 May 21
Entry into a Material Definitive Agreement
5:27pm
8-K
EX-10.1
ha4jg90g1kqo26d000
28 Dec 20
Entry into a Material Definitive Agreement
2:30pm
8-K
EX-10.2
1yo14f3dfjaodalto
28 Dec 20
Entry into a Material Definitive Agreement
2:30pm